OTC - ACTIVE INGREDIENT SECTION
Active ingredients
Each tablet contains:
Branhamella catarrhalis 200K
Influenzinum 200K
Klebsiella pneumoniae 200K
Micrococcus tetragenus 200K
Active ingredients
Each tablet contains:
Branhamella catarrhalis 200K
Influenzinum 200K
Klebsiella pneumoniae 200K
Micrococcus tetragenus 200K
Uses
For the temporary relief of cold and flu-like symptoms
Warnings
This product is not intended to be an alternative to
vaccination.
Do not use if you have ever had an allergic reaction to this
product or any of its ingredients.
Stop use and ask a doctor if symptoms continue to persist
after three days of use or are accompanied by a fever.
If pregnant or breastfeeding, ask a health professional before
use. Keep out of reach of children. In case of overdose, get
medical help or contact a Poison Control Center right away.
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
If pregnant or breastfeeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Inactive ingredients
Carboxymethylcellulose sodium, lactose monohydrate (milk), magnesium stearate, xylitol
Other information
Do not use if the blister pack has been tampered with.
Store in a cool, dry place.
Directions
Adults and Adolescents (12 years and older): At the first sign of symptoms, take one tablet allowing it to dissolve under the tongue. If
symptoms persist, take one tablet two or three times during the day or as recommended by your healthcare practitioner.
Children (6-11 years): Take under the direction of your healthcare practitioner.
Uses
For the temporary relief of cold and flu-like symptoms.
Directions
Adults and Adolescents (12 years and older): At the first sign of symptoms, take one tablet allowing it to dissolve under the tongue. If
symptoms persist, take one tablet two or three times during the day or as recommended by your healthcare practitioner.
Children (6-11 years): Take under the direction of your healthcare practitioner.
NDC 62106-6870-0
UNDA plex
MUCOCOCCINUM
Homeopathic Preparation
For the temporary relief of cold and flu-like symptoms.
10 Tablets
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62106-6870-0 | Muco coccinum | 10 in 1 BLISTER PACK | TABLET | 10 | 12 | |
| 62106-6870-0 | Muco coccinum | 1 in 1 BOX | TABLET | 1 | 12 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62106-6870 | MUCO COCCINUM (KLEBSIELLA PNEUMONIAE) TABLET [SEROYAL USA] | 12 | Current NDC, Legacy NDC, 2 package rows | 20221110_057b1c41-6946-602e-e054-00144ff88e88.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANAEROCOCCUS TETRADIUS | ACTIVE INGREDIENT | 7Q9DHH4FGG | 8 | |
| INFLUENZA A VIRUS | ACTIVE INGREDIENT | R9HH0NDE2E | 8 | |
| INFLUENZA B VIRUS | ACTIVE INGREDIENT | 1314JZ2X6W | 8 | |
| KLEBSIELLA PNEUMONIAE | ACTIVE INGREDIENT | 09PA36CT5R | 8 | |
| MORAXELLA CATARRHALIS SUBSP. CATARRHALIS | ACTIVE INGREDIENT | 1X259JGO78 | 8 | |
| ANAEROCOCCUS TETRADIUS | ACTIVE MOIETY | 7Q9DHH4FGG | 8 | |
| INFLUENZA A VIRUS | ACTIVE MOIETY | R9HH0NDE2E | 8 | |
| INFLUENZA B VIRUS | ACTIVE MOIETY | 1314JZ2X6W | 8 | |
| KLEBSIELLA PNEUMONIAE | ACTIVE MOIETY | 09PA36CT5R | 8 | |
| MORAXELLA CATARRHALIS SUBSP. CATARRHALIS | ACTIVE MOIETY | 1X259JGO78 | 8 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 8 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 8 | |
| XYLITOL | INACTIVE INGREDIENT | VCQ006KQ1E | 8 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62106-6870 | 62106-6870-0 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANAEROCOCCUS TETRADIUS | 7Q9DHH4FGG | ACTIB |
| INFLUENZA A VIRUS | R9HH0NDE2E | ACTIB |
| INFLUENZA B VIRUS | 1314JZ2X6W | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| KLEBSIELLA PNEUMONIAE | 09PA36CT5R | ACTIB |
| MORAXELLA CATARRHALIS SUBSP. CATARRHALIS | 1X259JGO78 | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| XYLITOL | VCQ006KQ1E | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| XYLITOL | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Muco coccinum | KLEBSIELLA PNEUMONIAE | Seroyal USA | 057b1c41-6946-602e-e054-00144ff88e88 | 2022-11-09 | Warnings | 62106-6870-0 62106-6870 62106687000 ed11f0cb-f2b5-732a-e053-2a95a90a6c45 057b1c41-6946-602e-e054-00144ff88e88 |
Adverse event summaries are temporarily unavailable. Other product information remains available.